Biblio

Export 3139 results:
Author [ Title(Desc)] Type Year
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
C
F. Zhang, Niu, L., Zhong, R., Li, S., and Le, W., “Chronic Sleep Disturbances Alters Sleep Structure and Tau Phosphorylation in AβPP/PS1 AD Mice and Their Wild-Type Littermates.”, J Alzheimers Dis, vol. 92, no. 4, pp. 1341-1355, 2023.
B. Han, Yu, L., Geng, Y., Shen, L., Wang, H., Wang, Y., Wang, J., and Wang, M., “Chronic Stress Aggravates Cognitive Impairment and Suppresses Insulin Associated Signaling Pathway in APP/PS1 Mice.”, J Alzheimers Dis, vol. 53, no. 4, pp. 1539-52, 2016.
S. L. Zuckerman, Brett, B. L., Jeckell, A., Yengo-Kahn, A. M., and Solomon, G. S., “Chronic Traumatic Encephalopathy and Neurodegeneration in Contact Sports and American Football.”, J Alzheimers Dis, vol. 66, no. 1, pp. 37-55, 2018.
L. T. Grinberg, Anghinah, R., Nascimento, C. Fernandes, Amaro, E., Leite, R. P., Martin, Mda Graça, Naslavsky, M. S., Takada, L. T., Filho, W. Jacob, Pasqualucci, C. A., and Nitrini, R., “Chronic Traumatic Encephalopathy Presenting as Alzheimer's Disease in a Retired Soccer Player.”, J Alzheimers Dis, vol. 54, no. 1, pp. 169-74, 2016.
S. Villarreal, Zhao, F., Hyde, L. A., Holder, D., Forest, T., Sondey, M., Chen, X., Sur, C., Parker, E. M., and Kennedy, M. E., “Chronic Verubecestat Treatment Suppresses Amyloid Accumulation in Advanced Aged Tg2576-AβPPswe Mice Without Inducing Microhemorrhage.”, J Alzheimers Dis, vol. 59, no. 4, pp. 1393-1413, 2017.
L. L. Law, Schultz, S. A., Boots, E. A., Einerson, J. A., Dougherty, R. J., Oh, J. M., Korcarz, C. E., Edwards, D. F., Koscik, R. L., N Dowling, M., Gallagher, C. L., Bendlin, B. B., Carlsson, C. M., Asthana, S., Hermann, B. P., Sager, M. A., Johnson, S. C., Cook, D. B., Stein, J. H., and Okonkwo, O. C., “Chronotropic Response and Cognitive Function in a Cohort at Risk for Alzheimer's Disease.”, J Alzheimers Dis, vol. 56, no. 1, pp. 351-359, 2017.
K. Nunez, Kay, J., Krotow, A., Tong, M., Agarwal, A. R., Cadenas, E., and de la Monte, S. M., “Cigarette Smoke-Induced Alterations in Frontal White Matter Lipid Profiles Demonstrated by MALDI-Imaging Mass Spectrometry: Relevance to Alzheimer's Disease.”, J Alzheimers Dis, vol. 51, no. 1, pp. 151-63, 2016.
K. R. LeVault, Tischkau, S. A., and Brewer, G. J., “Circadian Disruption Reveals a Correlation of an Oxidative GSH/GSSG Redox Shift with Learning and Impaired Memory in an Alzheimer's Disease Mouse Model.”, J Alzheimers Dis, vol. 49, no. 2, pp. 301-16, 2016.
M. Haddad, Perrotte, M., Landri, S., Lepage, A., Fülöp, T., and Ramassamy, C., “Circulating and Extracellular Vesicles Levels of N-(1-Carboxymethyl)-L-Lysine (CML) Differentiate Early to Moderate Alzheimer's Disease.”, J Alzheimers Dis, vol. 69, no. 3, pp. 751-762, 2019.
L. S. Nidadavolu, Feger, D., Wu, Y., Grodstein, F., Gross, A. L., Bennett, D. A., Walston, J. D., Oh, E. S., and Abadir, P. M., “Circulating Cell-Free Genomic DNA Is Associated with an Increased Risk of Dementia and with Change in Cognitive and Physical Function.”, J Alzheimers Dis, vol. 89, no. 4, pp. 1233-1240, 2022.
J. Mengel-From, Rønne, M. E., Carlsen, A. L., Skogstrand, K., Larsen, L. A., Tan, Q., Christiansen, L., Christensen, K., and Heegaard, N. H. H., “Circulating, Cell-Free Micro-RNA Profiles Reflect Discordant Development of Dementia in Monozygotic Twins.”, J Alzheimers Dis, vol. 63, no. 2, pp. 591-601, 2018.
H. Zong Ying Wu, Ong, K. Leung, Seeher, K., Armstrong, N. J., Thalamuthu, A., Brodaty, H., Sachdev, P., and Mather, K., “Circulating microRNAs as Biomarkers of Alzheimer's Disease: A Systematic Review.”, J Alzheimers Dis, vol. 49, no. 3, pp. 755-66, 2016.
P. Piscopo, Grasso, M., Puopolo, M., D'Acunto, E., Talarico, G., Crestini, A., Gasparini, M., Campopiano, R., Gambardella, S., Castellano, A. Elisa, Bruno, G., Denti, M. A., and Confaloni, A., “Circulating miR-127-3p as a Potential Biomarker for Differential Diagnosis in Frontotemporal Dementia.”, J Alzheimers Dis, vol. 65, no. 2, pp. 455-464, 2018.
M. C. de Olive Otto, H Y Wu, J., Thacker, E. L., Lai, H. Tsz Mung, Lemaitre, R. N., Padhye, N., Song, X., King, I. B., Lopez, O., Siscovick, D. S., and Mozaffarian, D., “Circulating Omega-3 and Omega-6 Fatty Acids, Cognitive Decline, and Dementia in Older Adults.”, J Alzheimers Dis, vol. 95, no. 3, pp. 965-979, 2023.
M. M. Ryan, Guévremont, D., Mockett, B. G., Abraham, W. C., and Williams, J. M., “Circulating Plasma microRNAs are Altered with Amyloidosis in a Mouse Model of Alzheimer's Disease.”, J Alzheimers Dis, vol. 66, no. 2, pp. 835-852, 2018.
D. A. Nation, Tan, A., Dutt, S., McIntosh, E. C., Yew, B., Ho, J. K., Blanken, A. E., Jang, J. Yun, Rodgers, K. E., and Gaubert, A., “Circulating Progenitor Cells Correlate with Memory, Posterior Cortical Thickness, and Hippocampal Perfusion.”, J Alzheimers Dis, vol. 61, no. 1, pp. 91-101, 2018.
L. Wang, Qiao, Y., Zhang, H., Zhang, Y., Hua, J., Jin, S., and Liu, G., “Circulating Vitamin D Levels and Alzheimer's Disease: A Mendelian Randomization Study in the IGAP and UK Biobank.”, J Alzheimers Dis, vol. 73, no. 2, pp. 609-618, 2020.
L. Xu, Zhang, W., Liu, X., Zhang, C., Wang, P., and Zhao, X., “Circulatory Levels of Toxic Metals (Aluminum, Cadmium, Mercury, Lead) in Patients with Alzheimer's Disease: A Quantitative Meta-Analysis and Systematic Review.”, J Alzheimers Dis, vol. 62, no. 1, pp. 361-372, 2018.
P. Gareri, Castagna, A., Cotroneo, A. Maria, Putignano, D., Conforti, R., Santamaria, F., Marino, S., and Putignano, S., “The Citicholinage Study: Citicoline Plus Cholinesterase Inhibitors in Aged Patients Affected with Alzheimer's Disease Study.”, J Alzheimers Dis, vol. 56, no. 2, pp. 557-565, 2017.
I. Beheshti, Maikusa, N., Daneshmand, M., Matsuda, H., Demirel, H., and Anbarjafari, G., “Classification of Alzheimer's Disease and Prediction of Mild Cognitive Impairment Conversion Using Histogram-Based Analysis of Patient-Specific Anatomical Brain Connectivity Networks.”, J Alzheimers Dis, vol. 60, no. 1, pp. 295-304, 2017.
D. G. Amen, Krishnamani, P., Meysami, S., Newberg, A., and Raji, C. A., “Classification of Depression, Cognitive Disorders, and Co-Morbid Depression and Cognitive Disorders with Perfusion SPECT Neuroimaging.”, J Alzheimers Dis, vol. 57, no. 1, pp. 253-266, 2017.
T. Nagata, Shinagawa, S., Nakajima, S., Plitman, E., Mihashi, Y., Hayashi, S., Mimura, M., and Nakayama, K., “Classification of Neuropsychiatric Symptoms Requiring Antipsychotic Treatment in Patients with Alzheimer's Disease: Analysis of the CATIE-AD Study.”, J Alzheimers Dis, vol. 50, no. 3, pp. 839-45, 2016.
A. R. Zammit, Hall, C. B., Katz, M. J., Muniz-Terrera, G., Ezzati, A., Bennett, D. A., and Lipton, R. B., “Class-Specific Incidence of All-Cause Dementia and Alzheimer's Disease: A Latent Class Approach.”, J Alzheimers Dis, vol. 66, no. 1, pp. 347-357, 2018.
V. Bonet-Costa, Herranz-Pérez, V., Blanco-Gandía, M. C., Mas-Bargues, C., Inglés, M., Garcia-Tarraga, P., Rodriguez-Arias, M., Miñarro, J., Borras, C., Garcia-Verdugo, J. Manuel, and Viña, J., “Clearing Amyloid-β through PPARγ/ApoE Activation by Genistein is a Treatment of Experimental Alzheimer's Disease.”, J Alzheimers Dis, vol. 51, no. 3, pp. 701-11, 2016.
S. M. Rao, Galioto, R., Sokolowski, M., Pierce, M., Penn, L., Sturtevant, A., Skugor, B., Anstead, B., Leverenz, J. B., Schindler, D., Blum, D., Alberts, J. L., and Posk, L., “Cleveland Clinic Cognitive Battery (C3B): Normative, Reliability, and Validation Studies of a Self-Administered Computerized Tool for Screening Cognitive Dysfunction in Primary Care.”, J Alzheimers Dis, vol. 92, no. 3, pp. 1051-1066, 2023.

Pages